tetano
Editor, Senior Moderator
Clin Neurol Neurosurg
. 2021 Jul 21;208:106839.
doi: 10.1016/j.clineuro.2021.106839. Online ahead of print.
Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination
Alberto Vogrig[SUP] 1 [/SUP], Francesco Janes[SUP] 2 [/SUP], Gian Luigi Gigli[SUP] 3 [/SUP], Francesco Curcio[SUP] 4 [/SUP], Ilaria Del Negro[SUP] 5 [/SUP], Serena D'Agostini[SUP] 6 [/SUP], Martina Fabris[SUP] 4 [/SUP], Mariarosaria Valente[SUP] 3 [/SUP]
Affiliations
Abstract
Several central and peripheral nervous system complications associated with the severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection have been recently described. An effective mass vaccination program is necessary to effectively reduce infection spread and, consequently, limit long-term sequelae, including those affecting the nervous system. Nevertheless, as more patients gain access to coronavirus disease 2019 (COVID-19) vaccines, it is important to report potential adverse events. Herein, we report a patient with previous history of post-infectious rhombencephalitis who developed an acute disseminated encephalomyelitis (ADEM) two weeks after being vaccinated for COVID-19.
Keywords: COVID-19; Encephalitis; Neurological adverse events; Neurological complications; Vaccine.
. 2021 Jul 21;208:106839.
doi: 10.1016/j.clineuro.2021.106839. Online ahead of print.
Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination
Alberto Vogrig[SUP] 1 [/SUP], Francesco Janes[SUP] 2 [/SUP], Gian Luigi Gigli[SUP] 3 [/SUP], Francesco Curcio[SUP] 4 [/SUP], Ilaria Del Negro[SUP] 5 [/SUP], Serena D'Agostini[SUP] 6 [/SUP], Martina Fabris[SUP] 4 [/SUP], Mariarosaria Valente[SUP] 3 [/SUP]
Affiliations
- PMID: 34325334
- DOI: 10.1016/j.clineuro.2021.106839
Abstract
Several central and peripheral nervous system complications associated with the severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection have been recently described. An effective mass vaccination program is necessary to effectively reduce infection spread and, consequently, limit long-term sequelae, including those affecting the nervous system. Nevertheless, as more patients gain access to coronavirus disease 2019 (COVID-19) vaccines, it is important to report potential adverse events. Herein, we report a patient with previous history of post-infectious rhombencephalitis who developed an acute disseminated encephalomyelitis (ADEM) two weeks after being vaccinated for COVID-19.
Keywords: COVID-19; Encephalitis; Neurological adverse events; Neurological complications; Vaccine.